Skip to main content

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Stem Cell Research & Therapy operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Manuscripts submitted to Stem Cell Research & Therapy will be evaluated initially by the Editors-in-Chief, and then assigned to an Associate Editor who is responsible for designating at least 2 reviewers in order to assess the scientific quality of the submitted material. The reviewers' comments will be considered by the Associate Editor and Editors-in-Chief and a final decision on publication will be made. They consider the quality of the manuscript from a scientific standpoint and its importance and significance in view of the scope of Stem Cell Research & Therapy.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 7.1
    5-year Journal Impact Factor: 7.9
    Source Normalized Impact per Paper (SNIP): 1.277
    SCImago Journal Rank (SJR): 1.798

    Speed 2023
    Submission to first editorial decision (median days): 34
    Submission to acceptance (median days): 211

    Usage 2023
    Downloads: 3,320,811
    Altmetric mentions: 1,402